[
  {
    "ts": null,
    "headline": "Here's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends",
    "summary": "Shares of AbbVie were recently trading for $212 apiece, and the company's total annual dividend amount (paid out over four quarters, like most dividend payers) is currently $6.56.  You'll get 152, which is the number of shares you'd need to own for a year to get $1,000 in dividend payments.  Note, too, that like many healthy and growing dividend payers, AbbVie has been hiking its payout annually.",
    "url": "https://finnhub.io/api/news?id=5c16ec8e037357270752cc0df3e203309b0354420d6ffae5e33bcefdadf92af5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742477460,
      "headline": "Here's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends",
      "id": 133324568,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Shares of AbbVie were recently trading for $212 apiece, and the company's total annual dividend amount (paid out over four quarters, like most dividend payers) is currently $6.56.  You'll get 152, which is the number of shares you'd need to own for a year to get $1,000 in dividend payments.  Note, too, that like many healthy and growing dividend payers, AbbVie has been hiking its payout annually.",
      "url": "https://finnhub.io/api/news?id=5c16ec8e037357270752cc0df3e203309b0354420d6ffae5e33bcefdadf92af5"
    }
  },
  {
    "ts": null,
    "headline": "Defensive Stocks For Unpredictable Trump Policy",
    "summary": "Navigate market volatility with defensive stocks, bonds, and gold.",
    "url": "https://finnhub.io/api/news?id=3a7f34c516b912e4da5e6ab19d098a97e373f71f94dfa6f751a599d77a1b754c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742469633,
      "headline": "Defensive Stocks For Unpredictable Trump Policy",
      "id": 133281246,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2185636755/image_2185636755.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Navigate market volatility with defensive stocks, bonds, and gold.",
      "url": "https://finnhub.io/api/news?id=3a7f34c516b912e4da5e6ab19d098a97e373f71f94dfa6f751a599d77a1b754c"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys",
    "summary": "February investments fell below $1,000, mainly in BDCs like Owl Rock Capital and Ares Capital, boosting annual dividend income by $77.",
    "url": "https://finnhub.io/api/news?id=468f86fd4b412eee1971a4620667bbda7347c15c7444f076c7a1ef8f0edb1137",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742463648,
      "headline": "My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys",
      "id": 133276011,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "February investments fell below $1,000, mainly in BDCs like Owl Rock Capital and Ares Capital, boosting annual dividend income by $77.",
      "url": "https://finnhub.io/api/news?id=468f86fd4b412eee1971a4620667bbda7347c15c7444f076c7a1ef8f0edb1137"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Health Care Fund Q4 2024 Commentary",
    "summary": "Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.",
    "url": "https://finnhub.io/api/news?id=8f81827abb6ec00be306ef52a83e31acbe2c243bf3d6f7d992305822a81d2a8e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742461500,
      "headline": "Invesco Health Care Fund Q4 2024 Commentary",
      "id": 133273550,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2154850841/image_2154850841.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.",
      "url": "https://finnhub.io/api/news?id=8f81827abb6ec00be306ef52a83e31acbe2c243bf3d6f7d992305822a81d2a8e"
    }
  }
]